A significant disparity regarding survival outcome for melanoma among European regions is well recognized and access to high quality care for European melanoma patients needs to be improved. There is an unmet need for the implementation of minimal standard of care within defined clinical pathways and Quality Assurance (QA) indicators.
The EU-MELACARE study aims to identify shared variables for cutaneous melanoma cases recorded in melanoma registries across Europe.
Material and methods
Opinion leaders involved in melanoma data registration and care quality analysis in 34 European countries were invited to respond to an expert survey covering questions regarding the melanoma registration practice in their countries and the characteristics, coverage and variables collected by the relevant melanoma registries.
Data regarding 13 melanoma registries from 11 European countries contributed to the study. The majority (61,5%) were population based registries and more than half (62%) had national coverage. The included registries collected a median of 38 variables (Interquartile Range, IRQ 21–76). We identified 24 shared variables available in >70% of registries.
This study provides valuable specific information on information recorded for melanoma cases are registered within Europe. A core of shared variables has been identified, which will constitute the basis for a standardized set of QA indicators for assessing and monitoring melanoma care across European countries.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Surgical Oncology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Global cancer incidence and mortality rates and trends-an update, cancer epidemiol.Biomarkers Prev. 2016; 25: 16-27
- Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study.Eur J Cancer. 2015; 51: 2179-2190
- Melanoma prognosis in Europe: far from equal.Br J Dermatol. 2014; 171: 179-182
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study.Lancet Oncol. 2014; 15: 23-34
- More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.Eur J Cancer. 2017; 75: 313-322
- Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.Arch Dermatol. 2008; 144: 629-636
- A population-based assessment of melanoma: does treatment in a regional cancer center make a difference?.J Surg Oncol. 2015; 112: 173-178
- Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.Melanoma Res. 2013; 23: 276-282
- Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.Eur J Cancer. 2015; 51: 653-667
- National assessment of melanoma care using formally developed quality indicators.J Clin Oncol. 2009; 27: 5445-5451
- Measuring the quality of melanoma surgery – highlighting issues with standardization and quality assurance of care in surgical oncology.Eur J Surg Oncol. 2017; 43: 561-571
- Quality assurance in surgical oncology the EURECCA platform.Eur J Surg Oncol. 2014; 40: 1387-1390
- The EURECCA project: data items scored by European colorectal cancer audit registries.Eur J Surg Oncol. 2012; 38: 467-471
- Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis.Eur J Cancer. 2015; 51: 1221-1230
- Common data items in seven European oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper GI).Eur J Surg Oncol. 2014; 40: 325-329
- Common variables in European pancreatic cancer registries: the introduction of the EURECCA pancreatic cancer project.Eur J Surg Oncol. 2016; 42: 1414-1419
- Cancer registries in Europe-going forward is the only option.Ecancermedicalscience. 2016; 12: 1-15
- Priorities and challenges for skin cancer prevention in Europe: an expert survey.Melanoma Res. 2013; 23: 298-306
- Age and casemix-standardised survival for all cancer patients in Europe 1999-2007: results of EUROCARE-5, a population-based study.Eur J Cancer. 2015; 51: 2120-2129
- Uses of cancer registries for public health and clinical research in Europe: results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010-2012.Eur J Cancer. 2015; 51: 1039-1049
- National evaluation of hospital performance on the new commission on cancer melanoma quality measures.Ann Surg Oncol. 2016; 23: 3548-3557
- Standardization and quality control of surgical treatment of cutaneous melanoma: looking for consensus of the Italian melanoma intergroup.Eur J Surg Oncol. 2015; 41: 148-156
- Dutch Melanoma Treatment Registry: quality assurance in the care of patients with metastatic melanoma in The Netherlands.Eur J Cancer. 2017; 72: 156-165
Published online: July 03, 2018
Accepted: June 21, 2018
© 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.